Valuation: Carvolix

Market Cap 387M 338M 319M 290M 542M 37.16B 545M 3.82B 1.47B 18.89B 1.45B 1.42B 60.79B P/E 2026 *
-12.5x
P/E 2027 * -12.5x
Enterprise Value 423M 369M 348M 316M 592M 40.57B 595M 4.17B 1.61B 20.62B 1.59B 1.55B 66.36B EV / Sales 2026 *
289x
EV / Sales 2027 * 12x
Free-Float
25.49%
Yield 2026 *
-
Yield 2027 * -
1 day+1.05%
1 week-1.71%
Current month-8.28%
1 month-4.95%
3 months+60.00%
6 months+70.92%
Current year+232.95%
1 week 5.7
Extreme 5.7
5.9
1 month 5.52
Extreme 5.52
7.32
Current year 1.73
Extreme 1.73
7.56
1 year 1.32
Extreme 1.32
7.56
3 years 0.93
Extreme 0.93
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 1,419,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-1.71%+269.23%+405.26% 387M
-0.40%-0.04%+24.26%+21.02% 12.51B
+0.66%-0.25%+11.35%+19.60% 6.52B
-1.09%-3.16% - - 6.13B
-0.21%+2.66%+28.03%+17.76% 5.54B
-1.53%-1.17%-20.26%+37.50% 4.99B
+0.38%+3.39%-32.45%-23.65% 3.9B
-0.18%+7.61%+31.52%-6.13% 1.94B
-1.17%-3.44%-17.16%+174.59% 1.71B
-1.95%+2.06%+48.74%-17.96% 1.57B
Average -0.44%+0.40%+38.14%+69.78% 4.52B
Weighted average by Cap. -0.44%+0.15%+13.26%+25.59%

Financials

2026 *2027 *
Net sales 1.46M 1.28M 1.21M 1.1M 2.05M 141M 2.06M 14.45M 5.58M 71.47M 5.5M 5.38M 230M 37.95M 33.09M 31.25M 28.37M 53.16M 3.64B 53.38M 374M 144M 1.85B 143M 139M 5.96B
Net income -37.46M -32.66M -30.84M -28M -52.47M -3.59B -52.69M -369M -143M -1.83B -141M -138M -5.88B -11.72M -10.22M -9.65M -8.77M -16.42M -1.12B -16.49M -116M -44.62M -572M -44.04M -43.06M -1.84B
Net Debt 35.51M 30.96M 29.23M 26.55M 49.74M 3.41B 49.95M 350M 135M 1.73B 133M 130M 5.57B 69.98M 61.02M 57.62M 52.32M 98.03M 6.71B 98.44M 690M 266M 3.41B 263M 257M 10.98B
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
59
Date Price Change Volume
21/09/26 5.760 +1.05% 5,906
18/09/26 €5.700 -1.38% 7,537
17/09/26 €5.780 -1.70% 9,730
16/09/26 €5.880 +1.38% 5,504
15/09/26 €5.800 -1.02% 15,739
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.700EUR
Average target price
8.775EUR
Spread / Average Target
+53.95%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!